New diabetes clinical trial: A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers

Published on: March 03, 2024 at 11:00PM
Conditions: Type2 Diabetes Mellitus
Interventions: Drug: BR3005; Drug: BR3005-1; Drug: BR3005-2
Sponsors: Boryung Pharmaceutical Co., Ltd
Recruiting
https://ift.tt/vCVwzBs